arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Sana Biotechnology, Inc.

SANA

$3.52 ▲ +0.10 (+3.08%) at close

27 Visible periods

18 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Sana Biotechnology, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $974.5M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -32.2% ↘

FCF / Share $-0.14

Trailing P/E —

Price / Book 8.0x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

27-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-47.21M

↑ +4.4% —

FCF / Share Free cash flow per share

$-0.14

↑ +33.8% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
EPS Growth YoY (%)	19.0% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	36.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-85.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	57.1% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	53.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	—	64.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-14.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-7.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	100.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-51.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	31.1% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	N/M	—	—	—	N/M	—	—	—	—	—	—	—
Net Income Growth YoY (%)	4.4% Caution ↓ Caution Declining Year-over-year change in net income	-19.9% Weak ↓ Weak Declining Year-over-year change in net income	54.0% Excellent ↑ Excellent Improving Year-over-year change in net income	54.0% Excellent ↑ Excellent Improving Year-over-year change in net income	54.0% Excellent ↑ Excellent Improving Year-over-year change in net income	44.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-30.9% Weak ↓ Weak Declining Year-over-year change in net income	-30.9% Weak ↑ Weak Improving Year-over-year change in net income	-30.9% Weak ↑ Weak Improving Year-over-year change in net income	-9.5% Weak ↑ Weak Improving Year-over-year change in net income	-161.1% Weak ↓ Weak Declining Year-over-year change in net income	-161.1% Weak ↓ Weak Declining Year-over-year change in net income	-161.1% Weak ↓ Weak Declining Year-over-year change in net income	27.4% Excellent ↓ Excellent Declining Year-over-year change in net income	82.6% Excellent Excellent Year-over-year change in net income	N/M	82.6% Excellent Excellent Year-over-year change in net income	—	-449.4% Weak Weak Year-over-year change in net income	N/M	-449.4% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	33.8% Excellent Excellent Year-over-year change in free cash flow	—	—	—	45.2% Excellent Excellent Year-over-year change in free cash flow	—	—	—	12.0% Fair Fair Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
FCF / Net Income (x)	0.80x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.57x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.67x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.76x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.99x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.00x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	2.71x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	1.04x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	0.31x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.33x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.41x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.07x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	-32.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-30.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-17.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-61.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-19.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-16.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-23.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-0.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-25.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-12.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	1.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-16.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	—	13.1% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	26.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	15.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-13.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-26.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-11.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-16.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-0.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-9.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-3.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-6.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	1.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-13.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—
Return on Common Equity (%) (%)	-39.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-364%)	-36.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-344%)	-25.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-269%)	-40.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-369%)	-23.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-257%)	-19.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-231%)	-36.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-345%)	-31.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-311%)	-28.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-291%)	-30.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-304%)	-22.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-250%)	-23.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-254%)	-19.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-228%)	-16.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-207%)	-5.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-137%)	-4.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-133%)	-4.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-130%)	-15.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-201%)	-21.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-245%)	2.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-86%)	-20.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-237%)	—	10.6% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-30%)	33.7% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+124%)	18.8% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+25%)	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Net Debt (USD)	$-83.80M	$-71.87M	$-103.36M	$-71.27M	$-96.13M	$-127.57M	$-127.00M	$-134.96M	$-177.05M	$-133.52M	$-168.45M	$-173.79M	$-160.46M	$-176.76M	$-163.34M	$-194.66M	$-188.52M	$-253.03M	$-433.67M	$-675.14M	$-750.69M	$-124.81M	—	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Basic EPS, GAAP (USD)	$-0.17	$-0.21	$-0.16	$-0.39	$-0.21	$-0.21	$-0.25	$-0.21	$-0.49	$-0.45	$0.00	$-0.59	$-0.43	$-0.42	$-0.45	$-0.39	—	$-0.61	—	$0.10	—	—	—	$-7.18	—	—	—
Free Cash Flow per Share (USD)	$-0.14	—	$-0.11	$-0.14	$-0.21	—	—	—	$-0.37	—	—	—	$-0.43	—	—	—	—	—	—	—	—	—	—	$-2.95	—	—	—
Book Value per Share (USD)	$0.44	$0.60	$0.74	$0.53	$0.93	$1.12	$1.31	$1.53	$1.70	—	$1.86	$1.80	$2.24	—	$2.98	$3.39	$3.76	—	$4.54	$5.02	$4.93	$-26.05	—	$-21.33	—	—	—
Tangible Book Value per Share (USD)	$-0.30	$-0.15	$-0.02	$-0.34	$0.04	$0.23	$0.42	$0.63	$0.79	—	$0.84	$0.79	$1.19	—	$1.93	$2.33	$2.69	—	$3.45	$3.91	$3.81	$-38.40	—	$-21.33	—	—	—
Basic Weighted Avg Shares (shares)	276.86M	—	260.49M	238.41M	237.58M	—	235.41M	234.44M	217.29M	—	196.98M	192.54M	191.23M	—	189.30M	187.63M	—	—	—	179.90M	—	—	—	12.23M	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$25.43M	$69.95M	$126.25M	$49.06M	$79.58M	$115.38M	$163.15M	$212.76M	$268.36M	—	$212.88M	$226.52M	$267.13M	—	$385.44M	$397.31M	$429.71M	—	$520.84M	$817.51M	$932.32M	$353.02M	—	—	—	—	—
Total Equity (USD)	$119.24M	$160.88M	$195.31M	$122.56M	$209.08M	$250.50M	$292.48M	$339.65M	$375.14M	$287.51M	$365.85M	$355.03M	$428.26M	$499.31M	$566.02M	$639.50M	$701.65M	$728.50M	$830.09M	$905.90M	$881.98M	$-421.18M	$-311.18M	$-260.93M	$-174.67M	$-142.54M	$-13.19M

📋 What is driving earnings? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Depreciation Expense (USD)	$2.39M	$3.10M	$3.20M	$2.90M	$3.65M	$3.80M	$4.10M	$3.90M	$3.70M	$4.21M	$4.50M	$4.50M	$4.35M	$4.17M	$4.00M	$3.80M	$3.61M	$3.37M	$2.80M	$2.60M	$2.25M	—	$1.60M	$1.40M	$1.26M	—	—
Net Income, GAAP (USD)	$-47.21M	$-58.83M	$-49.39M	$-49.39M	$-49.39M	$-49.07M	$-107.47M	$-107.47M	$-107.47M	$-88.12M	$-82.12M	$-82.12M	$-82.12M	$-80.44M	$-31.45M	$-31.45M	$-31.45M	$-110.73M	$-180.62M	$18.68M	$-180.62M	—	$-32.88M	$-87.81M	$-32.88M	—	—
Operating Cash Flow (USD)	$-37.38M	$-32.64M	$-29.43M	$-33.10M	$-48.66M	$-47.16M	—	—	$-65.63M	$-51.96M	—	—	$-79.27M	$-76.07M	—	—	$-77.71M	$-110.10M	—	—	$-49.91M	—	$-37.51M	$-33.37M	$-29.55M	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 27 quarters

Sana Biotechnology, Inc.

Analytical Summary

27-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare SANA with peers